Relationship Between Anti-Mu¨ llerian Hormone (AMH) and Insulin Levels During Different Tanner Stages in Daughters of Women With Polycystic Ovary Syndrome
Artículo
Open/ Download
Publication date
2012-02-16Metadata
Show full item record
Cómo citar
Sir Petermann, Lidia
Cómo citar
Relationship Between Anti-Mu¨ llerian Hormone (AMH) and Insulin Levels During Different Tanner Stages in Daughters of Women With Polycystic Ovary Syndrome
Author
Abstract
We have previously described increased serumlevels of anti-Mu¨llerian hormone (AMH) and stimulated insulin in daughters
ofwomenwith polycystic ovary syndrome(PCOS), suggesting that these girlsmay have an altered ovarian follicular developmentwhich
may be modulated by insulin. However, the specific relationship between serum AMH and insulin levels during each Tanner stage of
puberty in this cohort has not been established.Objective: The aim of our study was to establish the relationship between AMH and
poststimulated insulin serum concentrations during each stage of puberty in daughters of women with PCOS (PCOSd), compared
to daughters of control women (Cd). Design: We studied 135 PCOSd and 93 Cd classified according to their Tanner
stage. Gonadotrophins, sex steroids, sex hormone-binding globulin (SHBG), and AMH were determined in a fasting sample.
Ovarian volume was measured by pelvic ultrasound. In addition, in both groups we performed an oral glucose tolerance test
with measurements of glucose and insulin. Results: Anti-Mu¨llerian hormone levels were significantly higher in PCOSd compared
to Cd at all Tanner stages. Daughters of women with PCOS having AMH concentrations greater than 2 standard deviation (SD)
above the mean AMH value for the Cd group showed decreased serum follicle-stimulating hormone (FSH) concentrations and
increased stimulated levels of insulin during Tanner stages I, II, and III. Conclusions: Anti-Mu¨llerian hormone levels are
increased in PCOSd during all stages of puberty. We suggest that those PCOSd with the highest AMH levels probably represent
a group of girls with more severe ovarian dysfunction and metabolic derangements.
Quote Item
Reproductive Sciences 19(4) 383-390
Collections